Press Releases

Stay up to date on the latest company news:
14 October 2021

Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million

05 February 2020

Abalos Therapeutics Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts

15 October 2019

Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer

Events

Want to get in touch with the Abalos Therapeutics Team? Meet us at the following events:
Coming soon